Trích dẫn APA

Tarhini, A. A., Leng, S., Moschos, S. J., Yin, Y., Sander, C., Lin, Y., . . . Kirkwood, J. M. (2012). Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in-adjuvant with PF-3512676 and GM-CSF in metastatic melanoma.

Trích dẫn kiểu Chicago

Tarhini, Ahmad A., Siyang Leng, Stergios J. Moschos, Yan Yin, Cindy Sander, Yan Lin, William E. Gooding, và John M. Kirkwood. Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), Gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In-adjuvant With PF-3512676 and GM-CSF in Metastatic Melanoma. 2012.

Trích dẫn MLA

Tarhini, Ahmad A., et al. Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), Gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In-adjuvant With PF-3512676 and GM-CSF in Metastatic Melanoma. 2012.

Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.